Dataset from A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00008975
下载链接
链接失效反馈官方服务：
资源简介：
The goal for this study is to evaluate the efficacy and safety of tirzepatide versus placebo
in participants with type 2 diabetes not under control with diet and exercise alone. The
study will last approximately 47 weeks and may include about 15 visits.
创建时间：
2025-11-17
